These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1109 related articles for article (PubMed ID: 30796368)

  • 61. Detection of Minimal Residual Disease Using ctDNA in Lung Cancer: Current Evidence and Future Directions.
    Chae YK; Oh MS
    J Thorac Oncol; 2019 Jan; 14(1):16-24. PubMed ID: 30296486
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Liquid biopsy for rectal cancer: A systematic review.
    Massihnia D; Pizzutilo EG; Amatu A; Tosi F; Ghezzi S; Bencardino K; Di Masi P; Righetti E; Patelli G; Scaglione F; Vanzulli A; Siena S; Sartore-Bianchi A
    Cancer Treat Rev; 2019 Sep; 79():101893. PubMed ID: 31499407
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Integrating liquid biopsies into the management of cancer.
    Siravegna G; Marsoni S; Siena S; Bardelli A
    Nat Rev Clin Oncol; 2017 Sep; 14(9):531-548. PubMed ID: 28252003
    [TBL] [Abstract][Full Text] [Related]  

  • 64. What's new on circulating tumor cells? A meeting report.
    Lianidou ES; Mavroudis D; Sotiropoulou G; Agelaki S; Pantel K
    Breast Cancer Res; 2010; 12(4):307. PubMed ID: 20727231
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Tumour microenvironment: informing on minimal residual disease in solid tumours.
    Pantel K; Alix-Panabières C
    Nat Rev Clin Oncol; 2017 Jun; 14(6):325-326. PubMed ID: 28397823
    [No Abstract]   [Full Text] [Related]  

  • 66. Real-time liquid biopsy in cancer patients: fact or fiction?
    Pantel K; Alix-Panabières C
    Cancer Res; 2013 Nov; 73(21):6384-8. PubMed ID: 24145355
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Liquid biopsy: A new avenue in pathology.
    Ghosh RK; Pandey T; Dey P
    Cytopathology; 2019 Mar; 30(2):138-143. PubMed ID: 30485558
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Metastatic Melanoma: Liquid Biopsy as a New Precision Medicine Approach.
    Ricciardi E; Giordani E; Ziccheddu G; Falcone I; Giacomini P; Fanciulli M; Russillo M; Cerro M; Ciliberto G; Morrone A; Guerrisi A; Valenti F
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835424
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cell free circulating tumor nucleic acids, a revolution in personalized cancer medicine.
    Kerachian MA; Poudineh A; Thiery JP
    Crit Rev Oncol Hematol; 2019 Dec; 144():102827. PubMed ID: 31715326
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Circulating tumor DNA as a liquid biopsy target for detection of pancreatic cancer.
    Takai E; Yachida S
    World J Gastroenterol; 2016 Oct; 22(38):8480-8488. PubMed ID: 27784960
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Detection of Minimal Residual Disease and Its Clinical Applications in Melanoma and Breast Cancer Patients.
    Lin SY; Orozco JIJ; Hoon DSB
    Adv Exp Med Biol; 2018; 1100():83-95. PubMed ID: 30411261
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Liquid Biopsy: Approaches to Dynamic Genotyping in Cancer.
    von Bubnoff N
    Oncol Res Treat; 2017; 40(7-8):409-416. PubMed ID: 28693026
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clinical Implications of Monitoring Circulating Tumor DNA in Patients with Colorectal Cancer.
    Schøler LV; Reinert T; Ørntoft MW; Kassentoft CG; Árnadóttir SS; Vang S; Nordentoft I; Knudsen M; Lamy P; Andreasen D; Mortensen FV; Knudsen AR; Stribolt K; Sivesgaard K; Mouritzen P; Nielsen HJ; Laurberg S; Ørntoft TF; Andersen CL
    Clin Cancer Res; 2017 Sep; 23(18):5437-5445. PubMed ID: 28600478
    [No Abstract]   [Full Text] [Related]  

  • 74. Characterization of single circulating tumor cells.
    Alix-Panabières C; Pantel K
    FEBS Lett; 2017 Aug; 591(15):2241-2250. PubMed ID: 28459503
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The functional and clinical roles of liquid biopsy in patient-derived models.
    Zhu Z; Hu E; Shen H; Tan J; Zeng S
    J Hematol Oncol; 2023 Apr; 16(1):36. PubMed ID: 37031172
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Circulating tumor cells as biomarkers in head and neck cancer: recent advances and future outlook.
    Tinhofer I; Staudte S
    Expert Rev Mol Diagn; 2018 Oct; 18(10):897-906. PubMed ID: 30199647
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Genomic approaches to cancer and minimal residual disease detection using circulating tumor DNA.
    Semenkovich NP; Szymanski JJ; Earland N; Chauhan PS; Pellini B; Chaudhuri AA
    J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37349125
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A headlight on liquid biopsies: a challenging tool for breast cancer management.
    Massihnia D; Perez A; Bazan V; Bronte G; Castiglia M; Fanale D; Barraco N; Cangemi A; Di Piazza F; Calò V; Rizzo S; Cicero G; Pantuso G; Russo A
    Tumour Biol; 2016 Apr; 37(4):4263-73. PubMed ID: 26790442
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The Liquid Biopsy Consortium: Challenges and opportunities for early cancer detection and monitoring.
    Batool SM; Yekula A; Khanna P; Hsia T; Gamblin AS; Ekanayake E; Escobedo AK; You DG; Castro CM; Im H; Kilic T; Garlin MA; Skog J; Dinulescu DM; Dudley J; Agrawal N; Cheng J; Abtin F; Aberle DR; Chia D; Elashoff D; Grognan T; Krysan K; Oh SS; Strom C; Tu M; Wei F; Xian RR; Skates SJ; Zhang DY; Trinh T; Watson M; Aft R; Rawal S; Agarwal A; Kesmodel SB; Yang C; Shen C; Hochberg FH; Wong DTW; Patel AA; Papadopoulos N; Bettegowda C; Cote RJ; Srivastava S; Lee H; Carter BS; Balaj L
    Cell Rep Med; 2023 Oct; 4(10):101198. PubMed ID: 37716353
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cell-free DNA in large B-cell lymphoma: MRD and beyond.
    Sworder BJ; Kurtz DM
    Semin Hematol; 2023 Jul; 60(3):142-149. PubMed ID: 37474409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 56.